evolcSign inStart free
Menu

Cellcentric

Develops an oral cancer drug for people with multiple myeloma and other cancers

Cambridge, United KingdomFounded 2003cellcentric.comWebsite technologies

+ Add to sales board

Highlights

  • Hiring8 open roles
  • New on EvolcAdded 2026-11-01

About Cellcentric

CellCentric is a clinical-stage biopharmaceutical company developing inobrodib, an oral small-molecule inhibitor of p300/CBP, for multiple myeloma and other cancers. The drug is being evaluated in clinical trials, including in combination with standard-of-care therapies.

The company’s work includes drug research and clinical development. Its stated focus is improving treatment outcomes for people living with cancer.

CellCentric Limited is registered in Cambridge, United Kingdom, and was founded in 2003. Its listed roles include clinical operations, medical affairs, quality assurance, and business systems.

Product: Inobrodib, an oral small-molecule p300/CBP inhibitor in clinical development for multiple myeloma and other cancers.

Jobs at Cellcentric (8)

Cellcentric is hiring for 8 roles, mostly in operations, based in Burlington. One is remote.

Companies hiring like Cellcentric

Leadership

More biotech & pharma companies

  • Cellcraft

    AI bioprocess control software and related tools for biomanufacturers and bioprocess teams
    United KingdomBiotech & pharma1 open job

  • Centauri Therapeutics

    Develops Alphamer immunotherapies for infectious diseases, including Gram-negative bacterial infections in high-risk patients
    London, United KingdomBiotech & pharmaFounded 2014
    New on Evolc

  • Cerevance

    Develops cell-type-specific therapies and drug targets for patients with neurodegenerative, psychiatric and CNS disorders
    Cambridge, United KingdomBiotech & pharmaFounded 2016
    New on Evolc

  • Chemify

    Automated chemistry systems that help pharmaceutical and materials partners design and synthesize molecules
    Glasgow, United KingdomBiotech & pharmaFounded 201933 open jobs
    New on Evolc

  • Cizzle Biotechnology

    Non-invasive blood test for early lung cancer detection based on the CIZ1B biomarker, aimed at healthcare providers and patients
    London, United KingdomBiotech & pharmaFounded 2004
    New on Evolc

  • CNX Therapeutics

    Licenses and distributes specialty medicines for CNS and critical care conditions in 60+ markets
    London, United KingdomBiotech & pharmaFounded 19972 open jobs
    New on EvolcRemote-friendly

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Analytics

  • Google Analytics 4High confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content delivery

Content management

  • ElementorHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • WordPressHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.